Other
Argos
Argos is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
Assessment of Measurement Variability Across Automated Biometry Devices
NCT06045325
completed
Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study
NCT06085131
completed
Randomized Trial Comparing Prediction Accuracy of Two Swept Source Optical Coherence Tomography Biometers
NCT05748275
Clinical Trials (3)
Showing 3 of 3 trials
NCT06045325
Assessment of Measurement Variability Across Automated Biometry Devices
NCT06085131
Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study
NCT05748275
Randomized Trial Comparing Prediction Accuracy of Two Swept Source Optical Coherence Tomography Biometers
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3